AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
Globe Newswire • Tue Apr 22 2025
DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in Advanced Therapies Integrates North 2025, taking place on 30 April 2025 at the Usher Institute in Edinburgh.
DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) – AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in Advanced Therapies Integrates North 2025, taking place on 30 April 2025 at the Usher Institute in Edinburgh. As a recognised leader in expanding access to innovative therapies for complex, chronic and rare diseases, AscellaHealth will be represented by Gillian Molloy, vice president, Market Access, who will serve as a panellist during the session, Strength in Numbers, scheduled from 12:20 - 13:00.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.